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To the Editor—I am writing regarding the recent Value in Health
article concerning the issue of creating one language version of a
patient-reported outcome measure for use in multiple countries
(for example, one French version of a questionnaire that is suit-
able for use in Canada, France, and Belgium) [1].
The 2009 International Society for Pharmacoeconomics and
Outcomes Research (ISPOR) Task Force article addresses this
issue in-depth, concluding that there is no “right” way to
perform the procedure but that it depends on the measure, coun-
tries, and available timelines and budget of the individual project.
It was interesting therefore to hear the procedure proposed by the
authors of having a teleconference between each step of the
harmonization procedure heralded as creating a “superior ﬁnal
translation.”
In practice, it may be that the methodology is somewhat
cumbersome in comparison with some alternatives. Also the
problem as discussed in ISPOR’s 2009 Task Force report still
remains, that any translation achieved will be a compromise, no
matter how thorough or rigorous the teleconference at each step
is; it may be that the wording used is simply the “best available
alternative” for the countries involved and not the best wording
for each individual country.
Although an alternative procedure appears commendably
thorough, it may be that the extra time and cost involved with
multiple teleconferences (which heavily inﬂuence the budget of a
project) does not result in a translation which is superior to that
of an alternative methodology for creating a harmonized trans-
lation, which would be for a lead investigator (for example, the
French for France in-country language consultant might be
chosen as the “lead”) to create the reconciled translation and
reply to back translation queries, with suggestions then discussed
with the other investigators via e-mail. This method is therefore
less costly for the sponsors involved and still results in the reduc-
tion of “risk of inﬂuence of varying word structures” as the
authors mention.
It would be interesting to further compare the translated
results of the methodologies available to determine the merits of
this method.—Tamzin Furtado, BA (hons), Oxford Outcomes
Ltd., Oxford, UK.
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